Vertex Pharmaceuticals Incorporated

04/27/2023 | Press release | Distributed by Public on 04/27/2023 05:01

Vertex Receives CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 1 to <2 Years Old